Pharmacologic considerations in the treatment of anxiety and depression in medical practice.
D000328:Adult; D000661:Amphetamine / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001007:Anxiety / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D001341:Autonomic Nervous System / Q000503:physiopathology; D002319:Cardiovascular System / Q000503:physiopathology; D003863:Depression / Q000188:drug therapy* / Q000503:physiopathology; D004064:Digestive System / Q000503:physiopathology; D004357:Drug Synergism; D005239:Fear; D006167:Guilt; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D006998:Hypochondriasis / Q000209:etiology; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders / Q000209:etiology; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014566:Urogenital System / Q000503:physiopathology
D000928:Antidepressive Agents; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D000661:Amphetamine